41
Views
3
CrossRef citations to date
0
Altmetric
Drug Profile

Liraglutide, the once-daily human GLP-1 analog, in the treatment of Type 2 diabetes

&
Pages 495-505 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Devesh Sennik, Fahad Ahmed & David Russell-Jones. (2012) Exenatide, a GLP-1 agonist in the treatment of Type 2 diabetes. Expert Review of Endocrinology & Metabolism 7:1, pages 15-26.
Read now

Articles from other publishers (2)

Shaikha S. AlNeyadi, Naheed Amir, Mohammad A. Ghattas, Noor Atatreh, Shaikha S. Alketbi, Ruba Al Ajeil & Abdu Adem. (2020) Controlled Release of Pyrimidine Compound Using Polymeric Coated ZIF-8 Metal-Organic Framework as Glucagon-Like Peptide-1 Receptor Agonist Carrier. Molecules 25:18, pages 4313.
Crossref
Yu-Juan Zhang, Liu-Lan Shen, Hyae-Gyeong Cheon, Yong-Nan Xu & Jin-Hyun Jeong. (2013) Synthesis and biological evaluation of glucagon-like peptide-1 receptor agonists. Archives of Pharmacal Research 37:5, pages 588-599.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.